Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors
Open Access
- 12 June 2026
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 58 (6) , 1341-1352
Abstract
The majority of intestinal tumors harbor mutations in canonical Wnt pathway genes such as APC, whereas the lack of such alterations in a subset of tumors implies alternative tumorigenic routes. Here we identify recurrent in-frame deletion in COPA, frequently co-occurring with USP9X-truncating mutation, in small intestinal adenoma and adenocarcinoma. Patient-derived and CRISPR-engineered small intestinal organoids carrying COPA in-frame deletions exhibit R-spondin-independent yet Wnt ligand-dependent growth, maintaining LGR5 expression without canonical Wnt drivers. Mechanistically, COPA mutation stabilizes the Frizzled coreceptor LRP6 irrespective of R-spondin, sustaining Wnt pathway activation under growth factor-restricted conditions. USP9X loss further potentiates this phenotype. Unlike canonical Wnt pathway members, COPA encodes the α-subunit of coatomer complex I, which engages in vesicle trafficking with little prior linkage to intestinal tumorigenesis. Our findings establish COPA mutation as a unique and atypical intestinal tumor driver and implicate USP9X loss as a cooperating lesion.Keywords
Funding Information
- Exploratory Research for Advanced Technology (JPMJER2303)
- Japan Society for the Promotion of Science (22H04995)
- Japan Society for the Promotion of Science (24K21300)
- National Cancer Center Research and Development Fund
This publication has 55 references indexed in Scilit:
- Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndromeAnnals of the Rheumatic Diseases, 2025
- Evaluation of Systemic Treatments of Small Intestinal AdenocarcinomasJAMA Network Open, 2023
- APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenumJournal of Gastroenterology, 2021
- Panel gene profiling of small bowel adenocarcinoma: Results from theNADEGEprospective cohortInternational Journal of Cancer, 2020
- Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesThe Journal of Pathology, 2020
- Genomic Profiling of Small-Bowel AdenocarcinomaJAMA Oncology, 2017
- Whole‐exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β‐catenin signaling pathway mutationsCancer, 2016
- Mouse models of intestinal cancerThe Journal of Pathology, 2015
- Mapping RNA‐seq Reads with STARCurrent Protocols in Bioinformatics, 2015
- La FAM fatale: USP9X in development and diseaseCellular and Molecular Life Sciences, 2015